Aims and Scope
Antiviral Research is a monthly peer-reviewed medical journal published by Elsevier covering research on all aspects of the development of drugs, vaccines and immunotherapies against viruses of animals and plants. The journal was established in 1981 and is an official publication of the International Society for Antiviral Research. Like other Elsevier publications, it has been accused of limiting access of publicly funded research to rest of the population, including other scientists and researchers. The editor-in-chief is Mike Bray.
Key Metrics
15
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
144
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.9
5-Year SI
5-year SI
- N/A 2-year SI
- 0.9 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Virology
SJR
- Q2 Virology
- Q1 Pharmacology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.68
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
60%
4 to 6 months
35%
7 to 9 months
3%
Above 9 months
1%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
SJR
Topics Covered
- Virus
- Genotype
- Hepatitis B
- Dengue virus
- Sulfate
- Disease activity
- Antiviral therapy
- Severe acute respiratory syndrome coronavirus
- Neuraminidase
- Viral replication
- Hepatitis B virus
- Hepatitis C virus
- Viral rna
- Rabies virus
- Chronic infection
- Dual inhibitor
- Congenital cytomegalovirus infection
- Emetine
- Infectious bronchitis virus
- Hepatitis C
Journal Specifications
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1981 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Antiviral Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4′-fluorouridine
- 3 Dec 24
- Antiviral Research
-
Full paper
Crimean-Congo hemorrhagic fever virus replicon particle vaccine is safe and elicits functional, non-neutralizing anti-nucleoprotein antibodies and T cell activation in rhesus macaques
- 1 Dec 24
- Antiviral Research
-
Full paper
Editorial Board
- 1 Dec 24
- Antiviral Research
-
Full paper
Negative regulation of SREBP-1/FAS signalling molecules activates the RIG-1/TBK1-mediated IFN-I pathway to inhibit BVDV replication.
- 1 Dec 24
- Antiviral research
-
Full paper
Berberine promotes K48-linked polyubiquitination of HNF4α, leading to the inhibition of HBV replication.
- 1 Dec 24
- Antiviral Research
-
Full paper
Development of lipopeptide-based HIV-1/2 fusion inhibitors targeting the gp41 pocket site with a new design strategy
- 1 Dec 24
- Antiviral Research
Scite analysis
Powered by scite_
8.8k articles received 165.8k citations see all
- 4,727 Supporting
- 157,605 Mentioning
- 489 Contrasting
Editorial notices
- 2 Retractions
- 3 Withdrawals
- 0 Corrections
- 15 Errata
- 0 Expression of Concern
FAQs
How long has Antiviral Research been actively publishing?
Antiviral Research has been in operation since 1981 till date.
What is the publishing frequency of Antiviral Research ?
Antiviral Research published with a Monthly frequency.
How many articles did Antiviral Research publish last years ?
In 2023, Antiviral Research published 182 articles.
What is the eISSN & pISSN for Antiviral Research ?
For Antiviral Research,eISSN is 1872-9096 and pISSN is0166-3542.
What is Citescore for Antiviral Research ?
Citescore for Antiviral Research is 15.
What is H index for Antiviral Research ?
H index for Antiviral Research is 144.
What is SNIP score for Antiviral Research ?
SNIP score for Antiviral Research is 1.68.
What is the SJR for Antiviral Research ?
SJR for Antiviral Research is Q1.
Who is the publisher of Antiviral Research ?
ELSEVIER is the publisher of Antiviral Research.